AmCad BioMed Corporation (TPEX:4188)
11.05
-1.10 (-9.05%)
Nov 20, 2026, 1:30 PM CST
AmCad BioMed Market Cap
AmCad BioMed has a market cap or net worth of 699.83 million as of November 20, 2026. It is the 35,943rd most valuable company in the world and the 2,134th biggest in Taiwan. Its market cap has decreased by 27.30% in one year.
Market Cap
699.83M
Enterprise Value
447.73M
Revenue
26.16M
Global Rank
Country Rank
#2,134 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 26, 2013, AmCad BioMed's market cap has decreased from 905.63M to 699.83M, a decrease of -22.72%. That is a compound annual growth rate of -1.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 699.83M | -24.83% |
| Dec 31, 2025 | 930.99M | -34.23% |
| Dec 31, 2024 | 1.42B | -0.45% |
| Dec 29, 2023 | 1.42B | 67.51% |
| Dec 30, 2022 | 848.88M | -17.57% |
| Dec 30, 2021 | 1.03B | 0.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AViTA | 1.17B |
| Taiwan Biomaterial | 1.17B |
| Bioptik Technology Incorporation | 1.12B |
| S&S Healthcare Holding | 1.12B |
| Wiltrom | 846.37M |
| Rossmax International | 820.03M |
| Radiant Innovation | 745.23M |
| Carilex Medical | 651.76M |